
New Chapter in Online Sales of Obesity Drug Alternatives Tests Legal Boundaries
Unpacking the Role of AI in the Evolving Landscape of Obesity Medication In the rapidly shifting terrain of obesity treatment, artificial intelligence (AI) is emerging as a transformative force. While the original discussion centers on the challenges and innovations surrounding obesity drugs—particularly GLP-1 receptor agonists and their online alternatives—AI’s contributions weave through many layers of…